IMDX
Insight Molecular Diagnostics
IMDX
IMDX
23 hedge funds and large institutions have $21.1M invested in Insight Molecular Diagnostics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 25 → 23 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.14M | |
| 2 | +$1.01M | |
| 3 | +$89.3K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$69K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$51.2K |
Top Sellers
| 1 | -$131K | |
| 2 | -$84.3K | |
| 3 | -$9.98K | |
| 4 |
Renaissance Technologies
New York
|
-$5.31K |
| 5 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$1.96K |